BWCS
IMGN

Beirne Wealth Consulting Services’s Immunogen Inc IMGN Stock Holding History

Beirne Wealth Consulting Services’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,402
Closed -$58K – 190
2019
Q1 		$58K Hold
21,402
– – 0.05% 184
2018
Q4 		$103K Buy
+21,402
New +$130K 0.09% 172

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Beirne Wealth Consulting Services's IMGN Position: Q2 2019 in Review

Beirne Wealth Consulting Services sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 21,402 shares — an estimated $58K sold.

Beirne Wealth Consulting Services first reported a position in IMGN in Q4 2018 and held it in 2 quarters. The position peaked at $103K in Q4 2018. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • Beirne Wealth Consulting Services reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • Beirne Wealth Consulting Services sold 21,402 Immunogen Inc shares in Q2 2019, an estimated $58K.
  • Beirne Wealth Consulting Services first reported a position in Immunogen Inc in Q4 2018 and held it in 2 quarters.
  • Beirne Wealth Consulting Services's Immunogen Inc position peaked at $103K in Q4 2018.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Beirne Wealth Consulting Services's 13F filing for Q2 2019, filed 25 Jul 2019.